Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 27 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07690540
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
- Locations
-
- European Institute of Oncology Milan, Italy
NCT06960577
- Conditions
- Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
- Locations
-
- Research Site Chermside, Australia
- Research Site Elizabeth Vale, Australia
- Research Site Heidelberg, Australia
- Research Site Hong Kong, Australia
NCT06576921
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- The fourth hospital of Hebei Medical University Shijiazhuang, Heibei Province, China
- Department of Digestive surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' an, China Xi'an, Shaanxi, China
- Department of General Surgery, Tangdu Hospital, Air Force Medical University Xi'an, Shaanxi, China
- Department of General Surgery, The 986th Military Hospital, Air Force Medical University Xi'an, Shaanxi, China
NCT06647134
- Conditions
- Arthritis, Connective Tissue Diseases, Immune Checkpoint Inhibitors, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07512518
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +16 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT04572451
- Conditions
- Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT07034326
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, China
NCT05813418
- Conditions
- Immune Checkpoint Inhibitors, Immune-related Adverse Event, Immunotherapy, +1 more
- Locations
-
- CHU Amiens Picardie Amiens, Picardie, France
NCT06975384
- Conditions
- Cancer, Treatment-Related, Disease Attributes, Disease Progression, +17 more
- Locations
-
- Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China
NCT05477979
- Conditions
- Behavior, Behavioral Symptoms, Cancer, Treatment-Related, +16 more
- Locations
-
- Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China
NCT06446154
- Conditions
- Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen university cancer center Guangzhou, Guangdong, China
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
NCT07670715
- Conditions
- Immune Checkpoint Inhibitors, Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Neoadjuvant Chemoimmunotherapy, +1 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS
NCT07579247
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +18 more
- Locations
-
- Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China
Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy
NCT07372079
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, China
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
NCT07159217
- Conditions
- Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +7 more
- Locations
-
- Chinese Academy of Medical Sciences, Peking Union Medical College Hospital Beijing, China
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer
NCT07132008
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
- Locations
-
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
NCT06279403
- Conditions
- Clear-cell Metastatic Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma, Cytoreductive Nephrectomy, +1 more
- Locations
-
Not specified
NCT05898256
- Conditions
- Carcinoma, Head and Neck Neoplasms, Immune Checkpoint Inhibitors, +12 more
- Locations
-
Not specified
NCT07631611
- Conditions
- Brain Diseases, Brain Metastasis, Brain Neoplasms, +13 more
- Locations
-
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
NCT06629714
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Cancer, Treatment-Related, +18 more
- Locations
-
- Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China